Cita APA (7a ed.)
Phillips, W. J., Leong, R., Yeung, B., Al Lawati, A., Camidge, D. R., Lo, B., & Wheatley-Price, P. (2026). The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC. Current Oncology, 33(8), 439-449.
Cita Chicago Style (17a ed.)
Phillips, William J., Russell Leong, Benjamin Yeung, Ahmed Al Lawati, D. Ross Camidge, Bryan Lo, y Paul Wheatley-Price. "The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC." Current Oncology 33, no. 8 (2026): 439-449.
Cita MLA (9a ed.)
Phillips, William J., et al. "The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC." Current Oncology, vol. 33, no. 8, 2026, pp. 439-449.
Precaución: Estas citas no son 100% exactas.